Glimy Mv2 Tab

Composition

Glimepiride 2 mg + Metformin 500 mg (sustained/extended release) + Voglibose 0.2 mg

Uses of Glimy Mv2 Tab

Type 2 diabetes mellitus in adults, especially when blood sugar is not adequately controlled with diet/exercise and metformin alone; helps control post‑meal (postprandial) and fasting glucose

• •Lowers fasting and post-meal blood sugar
• •Improves insulin sensitivity
• •Reduces glucose absorption after meals
• •Helps achieve better HbA1c control
• •Supports long-term diabetes complication risk reduction with control

How it works

Glimepiride (a sulfonylurea) increases insulin release from pancreatic beta cells. Metformin improves insulin sensitivity and reduces glucose production by the liver. Voglibose slows carbohydrate digestion/absorption in the gut, reducing post‑meal blood sugar spikes.

Directions for use

Take exactly as prescribed. Usually taken once daily with the first main meal (or as directed). Swallow tablets whole; do not crush/chew (especially if SR/ER). Maintain diet and exercise; monitor blood glucose regularly.

Side effects

Common side effects of Glimy Mv2 Tab may include:

• •Hypoglycaemia
• •dizziness
• •headache
• •nausea